Viewing Study NCT04836728


Ignite Creation Date: 2025-12-26 @ 10:36 AM
Ignite Modification Date: 2026-01-01 @ 1:03 AM
Study NCT ID: NCT04836728
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-13
First Post: 2021-04-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung Cancer
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module